Keywords:
Migraine Disorders - Validation Study - Depression - Anxiety - Catastrophization
Palavras-chave:
Transtornos de Enxaqueca - Estudo de Validação - Depressão - Ansiedade - Catastrofização
INTRODUCTION
Locus of control (LOC) can be defined as a belief about the direction of control that
individuals have about various events in their lives. Individuals whose locus is internal
(LOC-I) believe that they can exert some influence on events through their own actions,
characteristics and competencies. These individuals can draw a causal relationship
between their behaviors and certain outcomes. In contrast, individuals whose locus
of control is external (LOC-E) believe that outcomes from events depend on luck, fate
or other individuals (powerful others), occurring independently of their own actions[1].
Health-related locus of control beliefs have been correlated with indicators of physical
and mental health[2],[3],[4], treatment adherence[5], health-related behavior[6], return to work[7] and quality of life[8]. Several authors have pointed out that pain beliefs and coping strategies influence
chronic pain and that those factors should be included among treatment targets[9]. Along with self-efficacy, locus of control is one of the cognitive factors that
ought to be evaluated in all patients with chronic headache[10]. Furthermore, chance locus of control (LOC-C) is among the psychological factors
associated with chronic migraine that are susceptible to modification[11]. While higher LOC-I (internal) is linked to higher overall migraine-related quality
of life, higher LOC-P and LOC-C (medical professionals and chance) are associated
with impairments in migraine-related quality of life[12].
Locus of control also moderates the relationship between headache pain and depression.
In a study conducted by Heath, Saliba, Mahmassabi, Major and Khoury[13], 71 headache patients were evaluated to examine in detail the relationship between
the severity of self-reported headache pain, depression and coping styles. The results
showed that higher levels of LOC-I were associated with lower levels of depression.
Also, LOC-I played a protective role in the model tested, thus reducing the strength
of the relationship between pain severity and depression.
Evaluation of LOC beliefs in the context of headache was put into operation through
construction of the Headache-Specific Locus of Control Scale (HSLC). In the study
on the construction and validation of the HSLC[14], LOC-C was positively associated with higher levels of depression, physical complaints,
catastrophizing as a strategy for coping with pain and increased disability. Moreover,
LOC-P was positively associated with higher levels of drug use and preference for
medical treatment and LOC-I was positively associated with a preference for self-regulation
treatments, such as biofeedback and relaxation training. All of these correlations
remained significant even after statistically controlling for intensity and frequency
of headaches. These results support the hypothesis that adaptation to headache-related
problems is influenced not only by the frequency and severity of headache episodes
but also by headache-specific locus of control beliefs.
Although the literature in this field indicates that it is relevant to investigate
locus of control among headache patients, there is a lack of instruments in Brazil
to evaluate this construct. The goal of this study was to test the cross-cultural
adaptation and psychometric properties of a Brazilian version of the HSLC on a sample
of patients at three tertiary-level headache centers in Brazil.
METHODS
Sample and procedure
The sample was composed of 134 migraine patients whose diagnosis was made by experienced
neurologists in accordance with the International Classification of Headache Disorders
3rd Edition - Beta version[15]. The exclusion criterion was the presence of medical conditions stated in the patients'
medical records that could lead to difficulties in understanding or filling out the
instruments, such as a previous diagnosis of a psychotic disorder or cognitive impairment.
The participants’ ages ranged from 18 to 65 years (M=43.70; SD=12.74). Participants
were selected from outpatients registered at two public hospitals and one private
hospital in southern Brazil. All of these headache centers are located in the city
of Porto Alegre, Rio Grande do Sul, Brazil.
The participants were found through the patient lists at the three hospitals’ headache
clinics. The inclusion period ran from April 2016 to March 2017. The instruments were
applied in a single session, on the same day as the patients’ routine doctor’s appointment.
All the participants gave their informed consent prior to their inclusion in the study.
The study received approval from each hospital’s institutional review board. [Table 1] shows the sociodemographic and clinical information of the sample. The HSLC was
translated forward and backward using standard guidelines for cross-cultural adaptation[16],[17].
Table 1
Sociodemographic and clinical data on the sample (n=134).
Factor
|
Distribution
|
Gender, n (%)
|
Female 119 (88.8%); male 15 (11.2%)
|
Age, years (SD)
|
44.5 (12.8)
|
Education, f (%)
|
Elementary=45 (33.6%); high school=47 (35%); professional=11 (8.2%); university/college=17
(12.7%); postgraduate=14 (10.5%)
|
Income (in current minimum monthly wages), n (%)
|
Up to 1 minimum wage=12 (9%); from 1 to 3=61 (45.5%); from 3 to 5=42 (31.3%); from
5 to 10=13 (9.7%); more than 10=6 (4.5%)
|
Labor status, n (%)
|
Employed=67 (50%); unemployed=67 (50%)
|
Marital status, n (%)
|
Single=34 (25.4%); married=55 (41%); living with partner=24 (17.9%); divorced=16 (11.9%);
widowed=5 (3.7%)
|
Diagnosis, n (%)
|
Episodic migraine=102 (76.1%); chronic migraine=18 (13.4%); medication overuse headache=14
(10.4%)
|
DD (years)/DT (years)
|
21.78 (14.67)/10.07 (10.72)
|
HF/HI
|
27.59 (24.43)/8.17 (2.01)
|
Mean (standard deviation); DD: duration of disease (in years); DT: duration of treatment
(in years); HF: headache frequency over the last three months in days; HI: headache
intensity attributed by the participants regarding their pain over the last three
months on a scale ranging from 0-10.
Measures
A semi-structured interview was conducted to characterize the sample and to evaluate
clinical headache parameters, such as duration of disorder in years (DD), patient’s
time under treatment (DT), headache frequency during the last three months (HF), headache
intensity during the last three months (HI) and screening for a diagnosis of medication
overuse headache.
Headache-Specific Locus of Control Scale
This instrument was developed by Martin, Kenneth and Penzien[14] and aims to evaluate individuals' perception that their headache is determined mainly
by internal factors, such as their own behavior, or external factors, such as healthcare
professionals or chance (for example, hormone fluctuation or genetically inherited
vulnerability). HSLC items were generated by professionals with experience in headache
treatment and items from the Multidimensional Health Locus of Control scale (MHLC).
After statistical procedures, the scale resulted in 33 items. The HSLC is composed
of three subscales (internal, chance and healthcare professionals) with 11 items each,
evaluated on a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
The instrument shows good reliability, with Cronbach's alpha of 0.84, 0.86, and 0.88
for each subscale, respectively.
Self-Reporting Questionnaire
This is a questionnaire for screening of psychiatric disorders at the primary care
level developed by Harding et al.[18] and validated in Brazil by Mari and Willians[19]. It is composed of 24 questions divided into two sections: 20 questions are aimed
at detection of “neurotic” disorders and the remaining four questions assess “psychotic”
disorders. The “neurotic” disorders comprise mood, anxiety and somatoform disorders,
assessed through the SCID-IV-TR (Structured Clinical Interview for DSM-IV-TR)[20]. In the present study, only the first section (neurotic disorders) was used. By
scoring 7 or more points on this subscale, individuals fulfill the criterion for a
possible neurotic disturbance.
Short form Health Questionnaire
The instrument is an indicator of overall health status and has eight scaled scores:
vitality (VT), physical functioning (PF), bodily pain (BP), general health perceptions
(GH), physical role functioning (PR), emotional role functioning (ER), social role
functioning (SF) and mental health (MH)[21],[22]. The Brazilian version of the SF-36 is considered to be a reliable and valid measure
of quality of life[23].
Headache Impact Test
This is a six-item questionnaire developed by Kosinski et al.[24] that is used to measure the impact of headaches on daily activities, including work,
school, social activities, pain intensity, fatigue and bedtime, frustration and concentration
difficulties. Each item is answered on a five-point Likert scale (6=never, 8=rarely,
10=sometimes, 11=very often and 13=always). The higher the score obtained is, the
greater the degree of impact also is. Martin et al.[25] examined the psychometric properties of the HIT-6 in 11 languages and 14 countries
and showed that the Portuguese version has good reliability, comparable with the original
version. The instrument has good internal consistency, with Cronbach's alpha of 0.79.
Pain Catastrophizing Scale
This instrument was originally developed by Sullivan et al.[26] to assess catastrophizing as a style of negative cognition relating to pain. Catastrophizing
refers to a single construct that is evaluated in three dimensions: magnification,
rumination and helplessness. In Brazil, the scale was adapted and validated by Sehn
et al.[27] and shows a good level of internal consistency, with Cronbach's alpha ranging from
0.86 to 0.93 among the magnification, rumination and helplessness subscales.
Patient Health Questionnaire and Generalized Anxiety Disorder 7
The PHQ-9 and GAD-7 are instruments for evaluating depression and anxiety in accordance
with the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),
respectively. The PHQ-9 is composed of nine items, evaluated on a four-point Likert
scale (0=not at all, 1=several days, 2=more than half the days and 3=nearly every
day). The total score can range from 0 to 27, and values greater than or equal to
10 are considered to be a positive indicator of major depression. The PHQ-9 is considered
to be a reliable and valid measure of depression severity[28]. In Brazil, this instrument was validated by Osório et al.[29] in the context of primary healthcare. The GAD-7 was developed by Spitzeret al.[30] and validated by Löwe et al.[31]. It is composed of seven items, evaluated on a four-point Likert scale (0=not at
all, 1=several days, 2=more than half the days and 3=nearly every day). The sum of
the scores ranges from 0 to 21. Values greater than or equal to 10 are positive indicators
of anxiety disorders. In the context of headache studies, both the PHQ-9 and the GAD-7
are considered to be reliable and valid screening instruments for major depressive
disorders and generalized anxiety disorders in patients with migraine[32],[33].
Data analysis
Descriptive statistical analyses were performed on the sociodemographic and clinical
data. The psychometric properties of the Brazilian version of the HSLC were analyzed
using confirmatory factor analysis (CFA), internal consistency and convergent validity.
In the CFA, the maximum likelihood (ML) estimation method was chosen, using the R
Studio software. We used the following adjustment indices with their respective reference
values: root mean square error of approximation (RMSEA≤0.05 or ≤0.08 with a 90% confidence
interval) and statistical significance using the chi-square test (p≥0.05). Internal
consistency was analyzed using the Cronbach’s α coefficient and composite reliability[34], considering the standard factorial loads of the items. Values greater than or equal
to 0.7 were considered adequate. Convergent validity was investigated by correlating
HSLC scores with the Self-Reporting Questionnaire (SRQ), SF-36, Headache Impact Test
(HIT-6), Pain Catastrophizing Scale (PCL), PHQ-9 and GAD-7. Additionally, multiple
regression analysis was conducted to examine the relative contributions of headache
frequency, headache intensity, depression, anxiety and LOC beliefs to the prediction
of headache-related disability. Inferential statistics were run using Statistical
Package for the Social Sciences (SPSS), version 22, adopting a 5% significance level.
RESULTS
A total of 134 patients were included. Because some patients could not fill out all
instruments, the number of patients included in the computations varied from 106 to
134 for each measure. [Table 1] shows the sociodemographic and clinical data for the sample. Descriptive statistics
for study measures are presented in [Table 2].
Table 2
Descriptive statistics on study measures.
Measure
|
Mean (SD)
|
Range
|
LOC-I (n=134)
|
36.34 (5.97)
|
29
|
LOC-P (n=134)
|
35.32 (5.75)
|
27
|
LOC-C (n=134)
|
40.60 (7.16)
|
35
|
PHQ-9 (n=133)
|
10.26 (6.71)
|
27
|
GAD-7 (n=134)
|
10.15 (6.15)
|
21
|
PCS (n=133)
|
42.80 (12.12)
|
46
|
SRQ (n=133)
|
10.15 (4.97)
|
20
|
HIT-6 (n=133)
|
62 (7.99)
|
38
|
PF
|
62.91 (29.32)
|
100
|
PR
|
39.92 (42.71)
|
100
|
BP
|
39.40 (22.27)
|
90
|
GH
|
8.17 (2.01)
|
8
|
VT
|
12.38 (3.80)
|
18
|
SF
|
57.56 (28.80)
|
100
|
ER
|
38.06 (43.48)
|
100
|
MH
|
55.01 (10.88)
|
68
|
SD: standard deviation; LOC-I: internal locus of control; LOC-P: healthcare professional
locus of control; LOC-C: chance locus of control; PHQ-9: Patient Health Questionnaire
9; GAD-7: Generalized Anxiety Disorder; PCS: Pain Catastrophizing Scale; HIT-6: Headache
Impact Test; PF: physical functioning; PR: physical role functioning; BP: bodily pain;
GH: general health perceptions; VT: vitality; SF: social role functioning; ER: emotional
role functioning; MH: mental health.
The three-factor structure of the HSLC (LOC-P, LOC-C and LOC-I) was confirmed through
confirmatory factor analysis (CFA). The model was adjusted to the empirical data (X2/d.f.=1.77, RMSEA=0.07 and SRMR=0.09), with factor loadings of between 0.35 and 0.72
for LOC-C; 0.55 and 0.69 for LOC-I and 0.40 to 0.63 for LOC-P. For LOC-P, item 27
(“When my doctor makes a mistake, I am the one to suffer from headaches"), item 12
(“Just seeing my doctor helps my headaches") and item 30 ("Health professionals keep
me from getting headaches") exhibited lower factor loadings: 0.17, 0.23 and 0.32 respectively.
Thus, the structure of the original version of the scale was retained in the Brazilian
version.
[Table 3] shows item correlations with the scale scores and Cronbach’s α of each HSLC subscale.
The Brazilian version of the HSLC showed good internal consistency, with Cronbach’s
α of 0.77.
Table 3
Item correlations with scale scores and Cronbach’s α of Headache-Specific Locus of
Control items.
HSLC subscale
|
Corrected item - total correlation, mean (range)
|
Cronbach’s α
|
Internal
|
0.58 (0.50-0.68)
|
0.87
|
Healthcare professionals
|
0.35 (0.16-0.52)
|
0.70
|
Chance
|
0.50 (0.35-0.64)
|
0.83
|
HSLC: Headache-Specific Locus of Control.
Convergent validity was evaluated by correlating HSLC scores with other study measures.
[Table 4] depicts the correlation matrix. Several correlations between study measures and
both LOC-I and LOC-P were statistically significant, such as psychopathological symptoms,
depression, anxiety, pain catastrophizing, headache-related disability and SF-36 domains.
Unlike the other subscales, LOC-C correlated only with headache frequency and headache
intensity. All three HSLC subscales (LOC-P, LOC-I and LOC-C) showed strong and statistically
significant correlations with total HSLC.
Table 4
Correlations between Headache-Specific Locus of Control Subscales and other studies.
|
1
|
2
|
3
|
HSLC
|
0.89**
|
0.68**
|
73**
|
LOC-P
|
-
|
|
|
LOC-I
|
0.56**
|
-
|
|
LOC-C
|
0.51**
|
0.08
|
-
|
SRQ
|
0.42**
|
0.41**
|
0.11
|
Depression
|
0.37**
|
0.40**
|
0.05
|
Anxiety
|
0.34**
|
0.37**
|
0.19
|
Pain catastrophizing
|
0.30**
|
0.39**
|
0.02
|
Headache frequency
|
-0.09
|
-0.06
|
0.23**
|
Headache intensity
|
0.07
|
0.09
|
0.27**
|
HIT-6
|
0.26**
|
0.40**
|
0.01
|
SF-36 domains
|
|
|
|
PF
|
-0.20*
|
-,33**
|
-0.04
|
PR
|
-0.37**
|
-,38**
|
-0.08
|
BP
|
-0.29**
|
-0.30**
|
-0.12
|
GH
|
-0.34**
|
-0.46**
|
0.02
|
VT
|
-0.34**
|
-0.12
|
-0.12
|
SF
|
-0.28**
|
-0.37**
|
-0.05
|
ER
|
-0.29**
|
-0.26**
|
-0.07
|
MH
|
-0.10
|
-0.23**
|
-0.04
|
*p<0.05; **p<0.01; HSLC: Headache-Specific Locus of Control scale; LOC-P: healthcare
professional locus of control; LOC-I: internal locus of control; LOC-C: chance locus
of control; SRQ: Self-Reporting Questionnaire; HIT-6: Headache Impact Test; PF: physical
functioning; PR: physical role functioning; BP: bodily pain; GH: general health perceptions;
VT: vitality; SF: social role functioning; ER: emotional role functioning role; MH:
mental health.
[Table 5] shows the results from a multiple regression analysis that was conducted to test
the contributions of headache frequency, headache intensity, psychopathological symptoms,
depression, anxiety, pain catastrophizing and LOC beliefs to prediction of headache-related
disability. Along with headache intensity, depression and pain catastrophizing, LOC-I
accounted for 45% of the variance in headache-related disability (R2 adjusted=0.45; F=12.97; p<0.01).
Table 5
Regression analysis for headache-related disability (n=134).
|
Beta
|
t
|
Sig
|
HF
|
0.09
|
1.34
|
0.18
|
HI
|
0.31
|
4.31
|
0.00**
|
SRQ
|
0.13
|
1.18
|
0.24
|
PHQ-9
|
0.28
|
2.34
|
0.02*
|
GAD-7
|
-0.10
|
-0.52
|
0.60
|
PCS
|
0.20
|
2.6
|
0.01*
|
LOC-I
|
0.19
|
2.18
|
0.03*
|
LOC-P
|
-0.18
|
-1.86
|
0.07
|
LOC-C
|
0.10
|
0.75
|
0.45
|
*p<0.05; **p<0.01. Method Enter. Durbin Watson: 2.12; HF: headache frequency; HI:
headache intensity; SRQ: Self-Reporting Questionnaire; PHQ-9: Patient Health Questionnaire
9; GAD- 7: Generalized Anxiety Disorder; PCS: Pain Catastrophizing Scale; LOC-P: healthcare
professional locus of control; LOC-I: internal locus of control; LOC-C: chance locus
of control.
DISCUSSION
The present study aimed to test the cross-cultural adaptation and psychometric properties
of a Brazilian version of the HSLC on a sample of patients from three tertiary-level
headache centers. In a CFA, the Brazilian version of the HSLC maintained the three-factor
structure from the original instrument and showed good internal consistency, with
Cronbach’s α of 0.77 for the full scale and 0.70, 0.83 and 0.87 for LOC-P, LOC-C and
LOC-I respectively.
LOC-I and LOC-P showed statistically significant correlations with psychopathological
symptoms (SRQ), depression (PHQ-9), anxiety (GAD-7), pain catastrophizing (PCS), headache-related
disability (HIT-6) and seven of the eight quality of life domains (SF-36). Unlike
the other subscales, LOC-C correlated only with headache frequency and headache intensity.
As in the HSLC original study[14], LOC-I scores were positively correlated with depression and headache-related disability
and LOC-P scores were positively correlated with pain catastrophizing and headache-related
disability. The direction and degree of those correlations were in line with the results
found in validation studies on other clinical populations[35],[36]. Moreover, the lack of correlations between the three LOCs and sociodemographic
variables (age, education labor status, income and marital status) demonstrates the
relevance of considering correlations with other psychological variables with which
LOC beliefs were associated.
The current results require a return to the conceptual issues of the construct investigated
in this study. “Internal believers" might feel responsible for both successes and
failures that happen to them. “External believers" might attribute their successes
to other people’s actions or to good fortune, or also blame other people, facts or
fate for their failures. In the case of headache patients, extreme internal believers
may display cognitive distortions such as personalization, blame or labeling regarding
their treatment or disease. Moreover, extreme external believers might become fatalistic
and display psychological distress, such as depressive and anxiety symptoms associated
with helplessness. Ultimately, LOC-I means engaging more frequently in actions that
decrease the risk of triggering a new episode of headache, LOC-P means relying on
others and on their knowledge to learn how to better manage headaches and LOC-C means
accepting the impossibility of having total control over all headache triggers. The
healthiest way to deal with headaches and their impact is by balancing all three LOCs.
It is important to consider the balance between the three LOCs for each individual,
thereby avoiding the risk of separate interpretation of LOC factors[37].
Along with headache intensity, depression and pain catastrophizing, LOC-I accounted
for 45% of the variance in headache-related disability. The inclusion of the internal
locus of control as a predictor of headache-related disability reinforces the need
for interventions in those beliefs. Patients need to have a sense of agency, for important
risk factors for chronic migraine to be modified. These factors include overuse of
acute migraine medication, ineffective acute treatment, obesity, depression and stress
life events[38]. As stated previously, LOC beliefs have been considered to be a relevant psychological
factor for all chronic headache patients[10].
The present study had some limitations that should be mentioned. All the patients
in the study were treated in tertiary-level healthcare centers and came from the southern
region of Brazil. Future studies on patients in different regions in Brazil and on
people who are not under routine treatment could provide further evidence of validity
for the HSLC and decrease the selection bias of the sample.
The Brazilian version of the HSLC was considered to be a valid and reliable measure
of headache-specific LOC beliefs. The instrument showed good internal consistency,
was significantly correlated with a variety of relevant clinical measures and was
considered to be a significant predictor of headache-related disability.